Original Research

Cumulative Irritation Potential Among Metronidazole Gel 1%, Metronidazole Gel 0.75%, and Azelaic Acid Gel 15%

Author and Disclosure Information

Topical therapy for rosacea aims to reduce inflammatory lesions and decrease erythema but can carry side effects such as stinging, pruritus, and burning. Metronidazole and azelaic acid gel 15% are US Food and Drug Administration–approved for the treatment of rosacea. The current study was conducted to assess the cumulative irritation potential of 2 formulations of metronidazole—0.75% gel and 1% gel—and azelaic acid gel 15% over 21 days (N=36). Results of this study demonstrated a significantly greater potential for irritation from azelaic acid compared with metronidazole gel 0.75% (P


 

Next Article: